Carisoprodol is metabolized in the liver by CYP2C19 to form meprobamate [see Scientific PHARMACOLOGY]. Co-administration of CYP2C19 inhibitors, including omeprazole or fluvoxamine, with SOMA could result in greater publicity of carisoprodol and lessened publicity of meprobamate. Carisoprodol is often a centrally acting skeletal muscle relaxant that does not instantly loosen https://whitneyf678plf3.bloggazzo.com/profile